Physician profile
Hamed Emami
NPI 1649650490
$20,407.05
in general payments reported to CMS, 2019-2025
9 companies · $3,046 in 2025
The $3,046 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,522 · 2023: $7,493 · 2024: $4,346 · 2025: $3,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $4,185 · Education: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,326.69 |
| Food and Beverage | $4,185.40 |
| Education | $373.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,736.61 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Biotronik INC. | $7,268.27 | 2021-2025 | Solia, Selectra, Acticor 7 Vr-T Dx |
| Medical Device Business Services, INC. | $1,431.81 | 2023 | Carto 3 |
| Abbott Laboratories | $1,258.19 | 2023-2025 | Aveir, Perclose Prostyle, Ensite |
| Boston Scientific Corporation | $513.47 | 2024-2025 | Watchman Flx |
| Biosense Webster, INC. | $102.81 | 2023-2024 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Atricure, INC. | $43.93 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.22 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $18.74 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamed Emami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.